Clinical Trial Update: S0000B: Vitamin E and/or Selenium in Preventing Cataract and Age-Related Macular Degeneration in Men on SELECT SWOG-S0000 [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating vitamin E and/or selenium for preventing cataract and age-related macular degeneration in men; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Cataract

Drugs mentioned

• Selenium (selenium)
• Vitamin E (tocopherol)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Cataract, Macular Degeneration | Phase 3 | Status: COMPLETED | Results posted: 2019-07-23